HomeBREAKING NEWS SII to Apply for DCGI Approval for Covovax Trial on Children; Vaccine has Great Potential to Save Future Generation, Says CEO June 26, 2021 Share Facebook Twitter Pinterest WhatsApp Covovax is the second Covid-19 vaccine candidate, which is being developed and manufactured at Pune-based SII. Previous articleAmbulance Driver Charges Rs 5 Lakh For Ferrying Covid Patient From Noida To VaranasiNext articleGoa-bound Rajdhani Express Derails Inside Tunnel in Maha; All Passengers Safe Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter 1 Dead, 4 Injured in House Collapse in Mumbai Chawl, MLA Accuses BMC of Not Sending Enough Help India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts